PriceTargets.com logo

Streamline Health Solutions - STRM Stock Price Target and Predictions

  • Consensus Rating: N/A
  • Consensus Price Target: $2.00
  • Forecasted Upside: 614.29%
  • Number of Analysts: 0
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 0 Buy Ratings
  • 0 Strong Buy Ratings
$0.28 As of 12/1/2023 09:55 PM ET
▼ -0.012 (-4.11%)

This chart shows the closing price for STRM by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Streamline Health Solutions Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for STRM and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for STRM

Analyst Price Target is $2.00
▲ +614.29% Upside Potential
This price target is based on 0 analysts offering 12 month price targets for Streamline Health Solutions in the last 3 months. The average price target is $2.00, with a high forecast of $2.00 and a low forecast of $2.00. The average price target represents a 614.29% upside from the last price of $0.28.

This chart shows the closing price for STRM for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is N/A

The current consensus among 0 polled investment analysts is to n/a stock in Streamline Health Solutions. This N/A consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
6/12/2022
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
9/10/2022
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
12/9/2022
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
3/9/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
6/7/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
9/5/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
11/4/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
12/4/2023

Latest Recommendations

  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
9/18/2023Lake Street CapitalLower Target$3.00 ➝ $2.00Low
11/21/2022Lake Street CapitalReiterated RatingBuy$3.00Low
5/20/2022Lake Street CapitalInitiated CoverageBuy$3.00Low
3/22/2022Colliers SecuritiesReiterated RatingBuyLow
3/3/2022Colliers SecuritiesReiterated RatingBuyLow
(Data available from 12/4/2018 forward)

News Sentiment Rating

0.44 (Hold)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 3 very positive mentions
  • 7 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
5/8/2023
  • 2 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
6/7/2023
  • 3 very positive mentions
  • 3 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
7/7/2023
  • 1 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
8/6/2023
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
9/5/2023
  • 5 very positive mentions
  • 4 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
10/5/2023
  • 2 very positive mentions
  • 4 positive mentions
  • 2 negative mentions
  • 0 very negative mentions
Mentions as of
11/4/2023
  • 0 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
12/4/2023

Current Sentiment

  • 0 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

  • No negative mentions tracked during this time.

Positive

Very Positive

  • No very positive mentions tracked during this time.
Streamline Health Solutions logo
Streamline Health Solutions, Inc. offers health information technology solutions and associated services for hospitals and health systems in the United States and Canada. The company offers RevID, an automated revenue reconciliation software; eValuator, a coding analysis platform; data comparison engine; coding and clinical documentation improvement (CDI) solutions, including CDI, abstracting, and physician query; and financial management solutions, such as accounts receivable management, denials management, claims processing, spend management, and audit management. It also provides auditing and coding, software, and professional services. The company sells its solutions and services through direct sales force and reseller partnerships. Streamline Health Solutions, Inc. was incorporated in 1989 and is based in Alpharetta, Georgia.
Read More

Today's Range

Now: $0.28
Low: $0.28
High: $0.29

50 Day Range

MA: $0.49
Low: $0.24
High: $0.97

52 Week Range

Now: $0.28
Low: $0.21
High: $2.35

Volume

72,700 shs

Average Volume

127,326 shs

Market Capitalization

$16.49 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.17

Frequently Asked Questions

What sell-side analysts currently cover shares of Streamline Health Solutions?

The following Wall Street research analysts have issued reports on Streamline Health Solutions in the last year: Lake Street Capital, and StockNews.com.
View the latest analyst ratings for STRM.

What is the current price target for Streamline Health Solutions?

1 Wall Street analysts have set twelve-month price targets for Streamline Health Solutions in the last year. Their average twelve-month price target is $2.00, suggesting a possible upside of 614.3%. Lake Street Capital has the highest price target set, predicting STRM will reach $2.00 in the next twelve months. Lake Street Capital has the lowest price target set, forecasting a price of $2.00 for Streamline Health Solutions in the next year.
View the latest price targets for STRM.

What is the current consensus analyst rating for Streamline Health Solutions?

Streamline Health Solutions currently has from Wall Street analysts. The stock has a consensus analyst rating of "N/A."
View the latest ratings for STRM.

What other companies compete with Streamline Health Solutions?

Other companies that are similar to Streamline Health Solutions include Healthcare Triangle, Mannatech, NeuroBo Pharmaceuticals, Aptose Biosciences and Forte Biosciences. Learn More about companies similar to Streamline Health Solutions.

How do I contact Streamline Health Solutions' investor relations team?

Streamline Health Solutions' physical mailing address is 11800 AMBER PARK DRIVE - SUITE 125, ALPHARETTA GA, 30009. The company's listed phone number is (888) 997-8732 and its investor relations email address is [email protected]. The official website for Streamline Health Solutions is www.streamlinehealth.net. Learn More about contacing Streamline Health Solutions investor relations.